Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
Public ClinicalTrials.gov record NCT02840721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2A, MULTICENTER, SINGLE ARM, OPEN- LABEL, TWO-STAGE, STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06480605 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, tolerability, and efficacy of PF-06480605 in subjects with moderate to severe ulcerative colitis.
Study identification
- NCT ID
- NCT02840721
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 26, 2016 (Actual)
- Primary completion
- May 31, 2018 (Actual)
- Completion
- Aug 30, 2018 (Actual)
- Last update posted
- Oct 23, 2023
2016 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Surgery Center of Aventura | Aventura | Florida | 33180 | — |
| Venture Ambulatory Surgical Center | North Miami Beach | Florida | 33162 | — |
| FQL Research, LLC | Pembroke Pines | Florida | 33027 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Brigham and Women's Hospital | Chestnut Hill | Massachusetts | 02467 | — |
| NYU Langone Long Island Clinical Research Associates | Great Neck | New York | 11021 | — |
| NYU Langone Nassau Gastroenterology Associates | Great Neck | New York | 11021 | — |
| New York Presbyterian Hospital-Weill Cornell Medical College | New York | New York | 10021 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Weill Cornell Medicine | New York | New York | 10021 | — |
| New York Presbyterian Hospital | New York | New York | 10065 | — |
| Allegiance Research Specialists, LLC | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02840721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2023 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02840721 live on ClinicalTrials.gov.